The authors provide valuable findings showing that GM-CSF prevents the loss of ILC3 populations during gut inflammation and inhibits pro-inflammatory cytokine production. They combine a preclinical ...
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...
A proteomics study shows that untreated HIV accelerates biological aging by ~10 years, but antiretroviral therapy can reverse ...
Many liver diseases share a common characteristic: fibrosis, the progressive accumulation of scarring in the liver tissue.
Zinc supports immunity and wound healing; deficiency may cause frequent illness or slow healing. Animal-based sources include ...
Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily pretreated PTCL population ...
Positive Full Results from Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Exceed Aclaris’ Target Profile, ...
Light-driven antioxidant nanomotors help reach injured kidney tissue and reduce the damage that allows kidney stone crystals ...
Nerve fibers within melanomas can slow their growth, according to a study led by Weill Cornell Medicine investigators. The ...
A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression.
Denovo Biopharma, a pioneer in applying precision medicine in central nervous system (CNS) diseases, today announced that the U.S. Patent and Trademark Office issued U.S. patent number 12,612,261, ...
About 1 in 8 Americans have used GLP-1s for weight loss — but more than three-quarters quit taking them within two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results